Yan V. Wang
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
Papers in
-
- Renal cell carcinoma treatment 3
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Cancer Treatment and Pharmacology 1
- Colorectal Cancer Treatments and Studies 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Carol Aghajanian (2 shared papers)Amreen Husain (3 shared papers)Barbara A. Goff (2 shared papers)Stephanie V. Blank (2 shared papers)Lawrence R. Nycum (2 shared papers)Wei Zou (1 shared paper)Gregg Fine (1 shared paper)Thomas Powles (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Gynecologic Oncology (2 papers)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Yan V. Wang
8 papers receiving 862 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Reproductive Medicine 201
- Oncology 527
- Immunology 258
- Pulmonary and Respiratory Medicine 276
- Immunology and Allergy 41
Countries citing papers authored by Yan V. Wang
This map shows the geographic impact of Yan V. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan V. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan V. Wang more than expected).
Fields of papers citing papers by Yan V. Wang
This network shows the impact of papers produced by Yan V. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan V. Wang. The network helps show where Yan V. Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan V. Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study Hit paper breakdown → | 2016 | 409 |
| 2 | 2015 | 222 | |
| 3 | 2014 | 149 | |
| 4 | 2020 | 41 | |
| 5 | 2020 | 30 | |
| 6 | 2014 | 18 | |
| 7 | 2013 | 7 | |
| 8 | 2014 | 2 |
About Yan V. Wang
Yan V. Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Immunology and Reproductive Medicine, having authored 8 papers that have together received 878 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Renal cell carcinoma treatment (3 papers), Phagocytosis and Immune Regulation (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Cancer Treatment and Pharmacology (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Reproductive Medicine (201 citations), Oncology (527 citations), Immunology (258 citations), Pulmonary and Respiratory Medicine (276 citations) and Immunology and Allergy (41 citations). Yan V. Wang has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Carol Aghajanian, Amreen Husain, Barbara A. Goff, Stephanie V. Blank, Lawrence R. Nycum, Wei Zou, Gregg Fine, Thomas Powles, David F. McDermott and Jeffrey R. Infante. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.